Viatris, a leading global healthcare company, has announced the appointment of Corinne Le Goff as its Chief Commercial Officer, effective immediately. Le Goff brings over 25 years of experience in the biotechnology and pharmaceutical sectors, having successfully led and nurtured teams worldwide. Her arrival strengthens Viatris’ Executive Leadership Team, positioning the company for continued growth.
With a solid scientific background and a reputation for visionary leadership, Le Goff has held key roles in various markets and therapeutic areas. Before joining Viatris, she served as President and CEO of Imunon, where she spearheaded a significant organizational transformation. Prior to that, Le Goff played a pivotal role as Chief Commercial Officer at Moderna, overseeing the commercialization strategy for their groundbreaking COVID-19 vaccine.
Her illustrious career also includes notable positions at Amgen, where she held leadership roles in both the United States and Europe, contributing to the company’s global success. Le Goff holds a Pharm.D. from Paris Descartes University and an MBA from La Sorbonne University, Paris.
Scott A. Smith, CEO of Viatris, expressed confidence in Le Goff’s ability to drive the company’s growth trajectory. He highlighted her extensive knowledge of the pharmaceutical and biotech industries, emphasizing her track record of success across diverse markets and geographies.
In response to her appointment, Le Goff expressed enthusiasm for joining Viatris during this pivotal moment in its journey. She underscored her commitment to improving patient care outcomes and praised Viatris’ dedication to reaching one billion patients annually. Le Goff looks forward to collaborating with Smith, the Executive Leadership Team, and the company’s commercial teams to fulfill Viatris’ mission and capitalize on future opportunities.
